TNGX
Tango Therapeutics·NASDAQ
--
--(--)
--
--(--)
TNGX fundamentals
Tango Therapeutics (TNGX) released its earnings on Mar 5, 2026: revenue was 0 (YoY -100.00%), missed estimates; EPS was -0.29 (YoY +17.14%), beat estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.29
+17.14%
Report date
Mar 5, 2026
Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Tango Therapeutics (TNGX) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Tango Therapeutics (TNGX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Tango Therapeutics (TNGX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Tango Therapeutics (TNGX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Tango Therapeutics (TNGX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Tango Therapeutics (TNGX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Tango Therapeutics's latest dividend and current dividend yield?Did Tango Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Tango Therapeutics's earnings call?What does Tango Therapeutics do and what are its main business segments?What is Tango Therapeutics's gross profit margin?What is the revenue and EPS growth rate for Tango Therapeutics year over year?What were the key takeaways from Tango Therapeutics’s earnings call?What factors drove the changes in Tango Therapeutics's revenue and profit?
